Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease.

MLA

Fanaroff, Alexander C., et al. “Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Valvular Heart Disease.” European Heart Journal Supplements : Journal of the European Society of Cardiology, vol. 24, no. Suppl A, Feb. 2022, pp. A19–31. EBSCOhost, https://doi.org/10.1093/eurheartj/suab151.

APA

Fanaroff, A. C., Vora, A. N., & Lopes, R. D. (2022). Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease. European Heart Journal Supplements : Journal of the European Society of Cardiology, 24(Suppl A), A19–A31. https://doi.org/10.1093/eurheartj/suab151

Chicago

Fanaroff, Alexander C, Amit N Vora, and Renato D Lopes. 2022. “Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Valvular Heart Disease.” European Heart Journal Supplements : Journal of the European Society of Cardiology 24 (Suppl A): A19–31. doi:10.1093/eurheartj/suab151.